Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 1
2006 2
2008 6
2009 4
2010 7
2011 2
2012 7
2013 7
2014 3
2015 10
2016 7
2017 4
2018 8
2019 8
2020 5
2021 7
2022 5
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.
Shatsky RA, Batra-Sharma H, Helsten T, Schwab RB, Pittman EI, Pu M, Weihe E, Ghia EM, Rassenti LZ, Molinolo A, Cabrera B, Breitmeyer JB, Widhopf Ii GF, Messer K, Jamieson C, Kipps TJ, Parker BA. Shatsky RA, et al. Among authors: jamieson c. Breast Cancer Res. 2024 Mar 13;26(1):46. doi: 10.1186/s13058-024-01805-w. Breast Cancer Res. 2024. PMID: 38481291 Free PMC article. No abstract available.
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer.
Shatsky RA, Batra-Sharma H, Helsten T, Schwab RB, Pittman EI, Pu M, Weihe E, Ghia EM, Rassenti LZ, Molinolo A, Cabrera B, Breitmeyer JB, Widhopf GF 2nd, Messer K, Jamieson C, Kipps TJ, Parker BA. Shatsky RA, et al. Among authors: jamieson c. Breast Cancer Res. 2024 Feb 26;26(1):32. doi: 10.1186/s13058-024-01782-0. Breast Cancer Res. 2024. PMID: 38408999 Free PMC article. Clinical Trial.
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells.
Botta GP, Chao J, Ma H, Hahn M, Sierra G, Jia J, Hendrix AY, Nolte Fong JV, Ween A, Vu P, Miller A, Choi M, Heyman B, Daniels GA, Kaufman D, Jamieson C, Li Z, Cohen E. Botta GP, et al. Among authors: jamieson c. J Immunother Cancer. 2024 Feb 5;12(2):e007927. doi: 10.1136/jitc-2023-007927. J Immunother Cancer. 2024. PMID: 38316518 Free PMC article.
Stem-Cell Aging and Pathways to Precancer Evolution.
Jamieson CHM, Weissman IL. Jamieson CHM, et al. N Engl J Med. 2023 Oct 5;389(14):1310-1319. doi: 10.1056/NEJMra2304431. N Engl J Med. 2023. PMID: 37792614 Review. No abstract available.
Getting to the core of ADAR2 activity in AML.
Steel K, Jamieson C. Steel K, et al. Among authors: jamieson c. Blood. 2023 Jun 22;141(25):3014-3015. doi: 10.1182/blood.2023019923. Blood. 2023. PMID: 37347500 No abstract available.
Telomerase-targeted therapies in myeloid malignancies.
Waksal JA, Bruedigam C, Komrokji RS, Jamieson CHM, Mascarenhas JO. Waksal JA, et al. Among authors: jamieson chm. Blood Adv. 2023 Aug 22;7(16):4302-4314. doi: 10.1182/bloodadvances.2023009903. Blood Adv. 2023. PMID: 37216228 Free PMC article. Review.
Stereochemical Control of Splice Modulation in FD-895 Analogues.
Chan WC, Trieger KA, La Clair JJ, Jamieson CHM, Burkart MD. Chan WC, et al. Among authors: jamieson chm. J Med Chem. 2023 May 25;66(10):6577-6590. doi: 10.1021/acs.jmedchem.2c01893. Epub 2023 May 8. J Med Chem. 2023. PMID: 37155693
104 results